Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib versus placebo in alveolar soft part sarcoma
ISRCTN63733470Phase 2Completed
- Sponsor
- The Institute of Cancer Research
- Start
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial in alveolar soft part sarcoma (ASPS) comparing Cediranib with Placebo (2 arms). Primary endpoint: Percentage change in sum of target lesion diameters. Started May 2011; status: completed.
02
Drugs
cediranib
03
Conditions
alveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on ISRCTN63733470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63733470.